FOLUSO ALAMINA: Open Payments
NPI 1407332737 · OREGON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 65 payments from 12 companies in 2025. Trend: 2023 $594 · 2024 $1,270 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $403 |
| Novo Nordisk Inc | 12 | $177 |
| Lilly USA, LLC | 9 | $109 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| PFIZER INC. | 3 | $57 |
| Exact Sciences Corporation | 2 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: UBRELVY, VRAYLAR, QULIPTA, MOUNJARO, Ozempic, Auvelity, Wegovy, Kerendia.
Industry payments across OH — which companies pay providers there.
